Marissa D. Zwan

3.7k total citations
71 papers, 1.8k citations indexed

About

Marissa D. Zwan is a scholar working on Psychiatry and Mental health, Physiology and General Health Professions. According to data from OpenAlex, Marissa D. Zwan has authored 71 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Psychiatry and Mental health, 29 papers in Physiology and 11 papers in General Health Professions. Recurrent topics in Marissa D. Zwan's work include Dementia and Cognitive Impairment Research (47 papers), Alzheimer's disease research and treatments (26 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Marissa D. Zwan is often cited by papers focused on Dementia and Cognitive Impairment Research (47 papers), Alzheimer's disease research and treatments (26 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Marissa D. Zwan collaborates with scholars based in Netherlands, United Kingdom and United States. Marissa D. Zwan's co-authors include Wiesje M. van der Flier, Philip Scheltens, Bart N.M. van Berckel, Charlotte E. Teunissen, Femke H. Bouwman, Frederik Barkhof, Rik Ossenkoppele, Adriaan A. Lammertsma, Ingrid S. van Maurik and Ronald Boellaard and has published in prestigious journals such as Brain, Neurology and Clinical Chemistry.

In The Last Decade

Marissa D. Zwan

67 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marissa D. Zwan Netherlands 26 1.3k 1.1k 315 228 225 71 1.8k
Stephanie J. B. Vos Netherlands 21 1.1k 0.9× 982 0.9× 276 0.9× 280 1.2× 227 1.0× 44 1.7k
Colin Groot Netherlands 21 897 0.7× 681 0.6× 444 1.4× 176 0.8× 188 0.8× 49 1.7k
Argonde C. van Harten Netherlands 19 1.1k 0.8× 807 0.8× 311 1.0× 269 1.2× 204 0.9× 68 1.6k
Marina Boccardi Italy 27 1.0k 0.8× 760 0.7× 450 1.4× 257 1.1× 156 0.7× 65 1.9k
Silke Kern Sweden 25 894 0.7× 840 0.8× 190 0.6× 287 1.3× 288 1.3× 121 2.3k
Il Han Choo South Korea 26 1.1k 0.9× 662 0.6× 538 1.7× 269 1.2× 123 0.5× 88 2.0k
Elana Koss United States 15 939 0.7× 697 0.6× 458 1.5× 173 0.8× 161 0.7× 29 1.7k
J. Scott Andrews United States 16 823 0.6× 569 0.5× 142 0.5× 159 0.7× 154 0.7× 44 1.5k
Thomas Mirsen Canada 8 965 0.8× 694 0.6× 401 1.3× 299 1.3× 198 0.9× 10 1.7k
Brandy R. Matthews United States 16 623 0.5× 534 0.5× 327 1.0× 203 0.9× 183 0.8× 36 1.6k

Countries citing papers authored by Marissa D. Zwan

Since Specialization
Citations

This map shows the geographic impact of Marissa D. Zwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marissa D. Zwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marissa D. Zwan more than expected).

Fields of papers citing papers by Marissa D. Zwan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marissa D. Zwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marissa D. Zwan. The network helps show where Marissa D. Zwan may publish in the future.

Co-authorship network of co-authors of Marissa D. Zwan

This figure shows the co-authorship network connecting the top 25 collaborators of Marissa D. Zwan. A scholar is included among the top collaborators of Marissa D. Zwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marissa D. Zwan. Marissa D. Zwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Soldevila‐Domenech, Natalia, Mariagnese Barbera, Jenni Lehtisalo, et al.. (2025). Adherence and intensity in multimodal lifestyle-based interventions for cognitive decline prevention: state-of-the-art and future directions. Alzheimer s Research & Therapy. 17(1). 61–61. 4 indexed citations
3.
Maurik, Ingrid S. van, Marissa D. Zwan, Freek Gillissen, et al.. (2024). Impact of COVID‐19 pandemic on mortality rate in memory clinic patients. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 16(1). e12541–e12541. 2 indexed citations
4.
Lee, Sven J. van der, Leonie N.C. Visser, Jetske van der Schaar, et al.. (2024). Interest in genetic susceptibility testing and disclosure of AD dementia risk in cognitively normal adults: a survey study. Alzheimer s Research & Therapy. 16(1). 1–1. 6 indexed citations
5.
Boer, Casper de, Marissa D. Zwan, Roos J. Jutten, et al.. (2024). Digital remote assessment of speech acoustics in cognitively unimpaired adults: feasibility, reliability and associations with amyloid pathology. Alzheimer s Research & Therapy. 16(1). 176–176. 3 indexed citations
6.
Ettema, Teake P., Marissa D. Zwan, Karin Dijkstra, et al.. (2023). FindMyApps compared with usual tablet use to promote social health of community-dwelling people with mild dementia and their informal caregivers: a randomised controlled trial. EClinicalMedicine. 63. 102169–102169. 7 indexed citations
7.
Deckers, Kay, Marissa D. Zwan, Jurgen A.H.R. Claassen, et al.. (2023). Study Design of FINGER‐NL: a Multidomain Lifestyle Intervention in Dutch Older Adults to Maintain Optimal Cognitive Functioning. Alzheimer s & Dementia. 19(S21).
8.
Maurik, Ingrid S. van, Marissa D. Zwan, Elsmarieke van de Giessen, et al.. (2023). How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment — a bidding game experiment. Alzheimer s Research & Therapy. 15(1). 208–208.
9.
Collij, Lyduine E., Gill Farrar, Marissa D. Zwan, et al.. (2023). Clinical outcomes up to 9 years after [18F]flutemetamol amyloid-PET in a symptomatic memory clinic population. Alzheimer s Research & Therapy. 15(1). 207–207. 1 indexed citations
10.
Vanbrabant, Jeroen, Sherif Bayoumy, Inge M.W. Verberk, et al.. (2023). Performance of optimized prototype LUMIPULSE G immunoassays for plasma pTau181 and pTau217. Alzheimer s & Dementia. 19(S24). 2 indexed citations
11.
Visser, Leonie N.C., Roos J. Jutten, Marissa D. Zwan, et al.. (2022). Everyday Functioning in a Community-Based Volunteer Population: Differences Between Participant- and Study Partner-Report. Frontiers in Aging Neuroscience. 13. 761932–761932. 8 indexed citations
12.
Visser, Leonie N.C., Francesca Mangialasche, Miia Kivipelto, et al.. (2022). Changes in Brain-Health Related Modifiable Risk Factors in Older Adults After One Year of COVID-19-Restrictions. Frontiers in Psychiatry. 13. 877460–877460. 4 indexed citations
13.
Zwan, Marissa D., Wiesje M. van der Flier, Lisa Vermunt, et al.. (2021). Dutch Brain Research Registry for study participant recruitment: Design and first results. Alzheimer s & Dementia Translational Research & Clinical Interventions. 7(1). e12132–e12132. 33 indexed citations
14.
Wimo, Anders, Mark Belger, Frank Jessen, et al.. (2021). A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer’s Disease: Results from the MOPEAD Project. Journal of Alzheimer s Disease. 83(3). 1149–1159. 6 indexed citations
15.
Winblad, Bengt, Frank Jessen, Milica G. Kramberger, et al.. (2020). The IMI‐EU H2020 project MOPEAD: Outcome of different screening methods to identify MCI/early AD. Alzheimer s & Dementia. 16(S6).
16.
Visser, Leonie N.C., Sven J. van der Lee, Jetske van der Schaar, et al.. (2020). Attitudes towards genetic susceptibility testing for Alzheimer’s disease dementia in cognitively normal adults: A survey study. Alzheimer s & Dementia. 16(S3). 2 indexed citations
17.
Kunneman, Marleen, Ellen M.A. Smets, Femke H. Bouwman, et al.. (2017). Clinicians' views on conversations and shared decision making in diagnostic testing for Alzheimer's disease: The ABIDE project. Alzheimer s & Dementia. 3(3). 305–313. 1 indexed citations
18.
Zwan, Marissa D., Femke H. Bouwman, Elles Konijnenberg, et al.. (2017). Diagnostic impact of [18F]flutemetamol PET in early-onset dementia. Alzheimer s Research & Therapy. 9(1). 2–2. 89 indexed citations
19.
Zwan, Marissa D., Rik Ossenkoppele, Nelleke Tolboom, et al.. (2014). Comparison of Simplified Parametric Methods for Visual Interpretation of 11C-Pittsburgh Compound-B PET Images. Journal of Nuclear Medicine. 55(8). 1305–1307. 22 indexed citations
20.
Flier, Wiesje M. van der, Rik Ossenkoppele, Sofie Adriaanse, et al.. (2012). O4‐03‐01: Differential impact of apolipoprotein E genotype on distributions of amyloid load and glucose metabolism in Alzheimer's disease. Alzheimer s & Dementia. 8(4S_Part_17). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026